Veronica D.
Therapeutics of the sage (NASDAQ: WISE) is allegedly suing Biogen (NASDAQ:BIIB) on the implementation of a standstill agreement following an unsolicited takeover bid valued at around $469 million.
The entire lawsuit, which was filed in a Delaware court, is sealed. A Sage court file (